🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is: • To assess the effects of a single...
Status
Completed
Location
Fortrea Clinical Research Unit Limited - Leeds
Start Date
2024-09-12
Trial ID
NCT06411860
Treatments Being Tested
The primary objective of the study is to evaluate the pharmacokinetics (PK)...
Status
Completed
Location
Inland Empire Clinical Trials, LLC
Start Date
2022-09-13
Trial ID
NCT05481411
Treatments Being Tested
The primary objective of this trial is to evaluate the effect of olpasiran,...
Status
Recruiting
Location
Bridgeport Hospital
Start Date
2026-03-23
Trial ID
NCT07293260
The primary objective of this study is to evaluate the pharmacokinetics (PK...
Status
Completed
Location
Inland Empire Clinical Trials, LLC
Start Date
2022-09-13
Trial ID
NCT05489614
Treatments Being Tested
The primary objective is to evaluate the effect of olpasiran, compared to p...
Status
Recruiting
Location
Advanced Cardiovascular LLC
Start Date
2025-08-22
Trial ID
NCT07136012
The main objective of this study is to evaluate the pharmacokinetics (PK) o...
Status
Completed
Location
Queen Mary Hospital
Start Date
2021-07-28
Trial ID
NCT04987320
Treatments Being Tested
Evaluate the effect of olpasiran administered subcutaneously (SC) compared ...
Status
Completed
Location
Westside Medical Associates of Los Angeles
Start Date
2020-07-28
Trial ID
NCT04270760
The primary objective of this trial is to compare the effect of treatment w...
Status
Active Not Recruiting
Location
Ascension Saint Vincents Birmingham
Start Date
2022-12-14
Trial ID
NCT05581303
Expanded access requests for Olpasiran may be considered for adult particip...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT07079267
Treatments Being Tested